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ABSTRACT 
 
The genes acrA and acrB, first identified in Escherichia coli encode components 
of a Resistance-Nodulation-Cell Division (RND) efflux system shown to be important 
for resistance to multiple antimicrobials. In Pseudomonas chlororaphis 30-84, 
transcriptional analysis demonstrated that the RpeA/RpeB two-component transduction 
system differentially regulated two genes immediately adjacent to rpeA and rpeB 
annotated as acrA and acrB. In the present study, I showed that constitutive expression 
of the 30-84 acrA/acrB genes conferred acriflavine resistance to E. coli and enhanced 
acriflavine resistance in 30-84 and also conferred resistance to tetracycline, 
chloramphenicol, and carbenicillin. Importantly, constitutive expression of acrA/acrB 
enhanced the growth of E. coli in the presence of ~300-800 µg of total phenazines 
extracted from 30-84, demonstrating the function of AcrA and AcrB in phenazine 
transport. Constitutive overexpression of the acrAB operon in trans in wild type 30-84 
resulted in enhanced phenazine production and transport. Phenazine production by the 
30-84 rpeB mutant was not rescued by overexpression of acrA/acrB unless other 
RpeA/RpeB controlled traits involved in the regulation of phenazine biosynthesis such 
as quorum sensing also were restored. Earlier and greater production and diffusion of 
phenazines significantly increased the capacity of 30-84 to inhibit fungal growth. These 
data indicated that acrA/acrB enhanced RND-type transporter activities and phenazine 
transport. Based on the findings from this study, a model is proposed to illustrate how 
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phenazine transport and biosynthesis are related in 30-84 and whether transport may 
contribute to positive catabolic feedback regulation of phenazine biosysnthesis. 
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1. INTRODUCTION  
 
Pseudomonas chlororaphis 30-84 is a biological control agent that has been 
studied extensively because it has the capacity to suppress take-all disease of wheat 
caused by the fungal pathogen Gaeumannomyces graminis var. tritici when applied to 
wheat seeds or seed beds (1). Take-all is a wilt disease of wheat and barley that is one of 
the most important root diseases of wheat in the world (1). 
Pseudomonas chlororaphis 30-84 produces bright orange-colored secondary 
metabolites known as phenazines that are important for the strain’s ability to inhibit 
pathogens, colonize the plant rhizosphere, and form biofilms (2). Phenazines are 
compounds with a nitrogen-containing ring structure that differ from one another on the 
basis of the substitutive groups attached to the aromatic backbone (3). They are redox 
active compounds that are toxic to a variety of microbes and are capable of altering the 
environment outside of cells (3).  
Previous work demonstrated that, like many secondary metabolites, the 
production of phenazines by 30-84 is controlled by a complex regulatory network (4). 
This network includes the PhzI/PhzR quorum sensing system and multiple two 
component signal transduction (TCST) systems, including RpeA/RpeB (4). Quorum 
sensing is a strategy used by many Gram negative bacteria to regulate the expression of 
secondary metabolites according to the density of accumulated bacterial signal 
molecules (5). In 30-84, the PhzI/PhzR quorum sensing system directly regulates the 
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transcription of the phenazine biosynthetic operon (6). In contrast, TCSTs serve as a 
basic mechanism to allow organisms to sense and respond to changes in environmental 
conditions. These systems typically consist of a membrane-bound histidine kinase sensor 
(HK) and a cytoplasmic response regulator (RR) and typically control multiple 
biosynthetic operons and their regulators (4). In 30-84, RpeA (a sensor protein) and 
RpeB (the cognate response regulator) control phenazine biosynthesis via the regulation 
of Pip, a TetR transcriptional regulator homolog, and the PhzI/PhzR quorum sensing 
system (4).  
I hypothesize that due to the redox activity of these secondary metabolites, 
phenazine production and transport are likely to be coordinately regulated. Coordinated 
regulation may be needed to enable bacterial cells to protect themselves from potentially 
damaging redox activity and to insure that phenazines are exported outside the cell, 
where they exert significant influence on the environment and biological control 
activities (7-9) (See Literature Review). Support for this hypothesis was garnered 
recently when it was shown that the RpeA/RpeB TCST controls both the production and 
accumulation of phenazines in supernatants (4). 
The RpeA/RpeB TCST system was originally identified by random mutagenesis 
(10). A mutant with defects in rpeA appeared dark orange on plates, demonstrating that 
rpeA represses phenazine production (e.g. when it was mutated the result was 
over-expression and heavy diffusion of phenazines into the media). In contrast, a 
mutation in rpeB resulted in reduced phenazine production, suggesting positive control 
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of phenazines by RpeB (fig. 1). Mutants with defects in both rpeA and rpeB have the 
rpeB mutant phenotype. 
Figure 1. The phenotype of wild type 30-84 and the rpeA and rpeB mutants on Luria-Bertani 
(LB) medium. Notice the mutations of rpeA and rpeB result in more versus less phenazine 
production and diffusion into the agar medium, respectively, compared to the wild type. Greater 
phenazine production and diffusion result in greater inhibition of the fungus Gaeumannomyces 
graminis. 
In order to gain a better understanding of how RpeA/RpeB control phenazine 
production, transcriptomic analysis of rpeA and rpeB mutants compared to the wild type 
was conducted using RNA-Seq (Pierson, unpublished). Data from the RNA-Seq analysis 
demonstrated that two genes, annotated as acrA and acrB and located next to rpeA and 
rpeB on the bacterial chromosome (fig. 2), were among the most highly up-regulated in 
the rpeA mutant and the most highly down regulated in the rpeB mutant relative to wild 
type, respectively. The genes acrA and acrB are annotated as acriflavine resistance 
genes, (hence the acronym acr for acriflavine resistance) (11). Acriflavine, derived from 
acridine, is a type of antibiotic capable of inhibiting the growth of some fungi and 
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bacteria (12) and which also has structural similarity to phenazines (fig. 2). The 
differential regulation of acrA/acrB by RpeA and RpeB was confirmed via quantitative 
real-time PCR (fig. 3) (Pierson, unpublished).  
 
Figure 2. The structures of 2-OH-PCA (2 hydroxy-phenazine carboxylic acid, a phenazine 
produced by 30-84) and acriflavine. The location of the acrA/acrB genes relative to rpeA/rpeB 
on the bacterial chromosome is also shown.  
 
Figure 3. The relative transcript abundances of acrB (purple) and acrA (green) in the rpeA and 
rpeB mutants relative to wild type. Transcript abundance is expressed as a relative quotient 
(RQ), defined as the ratio of the transcript abundance from the mutant to the wild type, e.g.  
   
transcript ab n ance m tant   
transcript ab ncance wil  type
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In E. coli, Pseudomonas, and other Gram negative bacteria acrA and acrB 
encode components of a Resistance-Nodulation-Cell Division (RND) efflux system 
shown to be important for resistance to antimicrobials, including the antibiotic 
acriflavine (13) (see Literature Review). Consistent with the hypothesis that the 30-84 
acrA/acrB genes, which are regulated by the RpeA/RpeB TCST, also encode an RND 
efflux system, in a preliminary experiment I found that rpeA mutants are more resistant 
to acriflavine than the wild type, whereas rpeB mutants are significantly less resistant to 
acriflavine than either wild type or rpeA mutants (fig. 4). Based on similarity in the 
structure of acriflavine and phenazines and the higher levels of phenazine accumulated 
in the liquid supernatant of rpeA mutants, I hypothesize that the acrA/acrB genes also 
function in the export of phenazines outside the cell. 
 
Figure 4. Growth of the wild type and the rpeA mutant on LB plates containing 0.01% 
acriflavine. Notice that the rpeA mutant has significantly more growth and is able to produce 
more phenazine than the wild type in the presence of acriflavine. The rpeB mutant is almost 
completely susceptible to 0.01% acriflavine (data not shown). 
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 In this study, I used a genetic approach consisting of a) constitutive gene 
expression and b) gene deletion studies to evaluate the hypotheses that the 30-84 acrA 
and acrB genes function as an RND type transporter 1) capable of conferring multi-drug 
resistance and 2) transporting phenazines. For the constitutive gene expression studies, 
the 30-84 acrA/acrB genes were PCR amplified and cloned behind the constitutive 
promoter Ptac, a modified lac operon promoter, in the broad host range vector KT2 (fig. 
5A) (14). This vector was then transferred to E. coli, wild type 30-84 and various mutant 
derivatives of 30-84 (e.g. ∆rpeA and ∆rpeB mutants, and ∆acrA, once constructed) to 
evaluate the effect of constitutive expression of the acrA/acrB genes on drug resistance 
and phenazine biosynthesis and transport. For the gene deletion studies, recombination 
fragments consisting of a kanamycin cassette with its own promoter flanked by a 100 nt 
arm having homology to acrA were generated via PCR using plasmid pUC4K as a 
template (fig. 5B). The recombination fragment was then transformed into wild type 
30-84 and screened for homologous recombination resulting in the replacement of the 
majority of region of the bacterial chromosome encoding these genes by the KMR 
marker (except for the first and last 100 nt). Thus far I have not identified a homologous 
recombinant. The resulting mutant, once obtained, will be assessed for loss of transport 
function and more specifically loss or reduced phenazine transport function.  
 I summarize the current findings by proposing a hypothetical model describing 
the regulation and function of the acrA/acrB genes in phenazine biosynthesis and 
transport and the biological control activity of P. chlororaphis 30-84 (see Discussion). 
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Figure 5. Methods for constitutive gene expression and gene deletion studies. A. For the 
constitutive gene expression studies, the 30-84 acrA/acrB genes were PCR amplified and cloned 
behind the constitutive promoter Ptac into either plasmid KT2 (KmR) or GT2 (GmR). This vector 
was then transferred to E. coli, wild type 30-84 and various mutant derivatives of 30-84 resulting 
in the constitutive expression the acrA/acrB genes in trans. B. For the gene mutation studies, a 
recombination fragment consisting of a kanamycin cassette with its own promoter flanked by a 
100 nt arm having homology to either acrA was generated. The recombination fragments were 
then transformed into wild type 30-84 and screened for homologous recombination, resulting in 
the replacement of the majority of the coding region in the bacterial chromosome by the KMR 
marker. 
 
 
 
 
 
B. 
B.. 
A. 
B.. 
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2. LITERATURE REVIEW 
 
The association between plants and microorganism can be beneficial, neutral or 
pathogenic. Among the beneficial soilborne microbes, rhizobacteria have drawn 
considerable attention because they are more likely to possess characteristics that make 
them well suited as biological control agents or plant growth promoting rhizobacteria 
(PGPR) (15). Pseudomonas spp. have several traits that enable them to be good PGPR, 
including a) the ability to grow rapidly and utilize seed and root exudates to better 
colonize the rhizosphere, and b) the ability to produce a wide spectrum of bioactive 
compounds such as antibiotics to inhibit plant pathogenic microorganisms (16). 
Fluorescent pseudomonads that serve as biological control agents produce various 
secondary metabolites that have been identified as powerful mechanisms of disease 
control, including phenazines, 2,4-diacetylphloroglucinol, pyoluteorin, and pyrrolnitrin. 
These secondary metabolites are recognized as antibiotics because of their role in plant 
pathogen inhibition (17-19).  
Many bacterial species including members of the genera Pseudomonas, 
Streptomyces and Burkholderia produce redox-active compounds known as phenazine 
(20). Phenazines are compounds with a nitrogen-containing ring structure that differ 
from one another on the basis of the substitutive groups attached to the aromatic 
backbone (3). Different species often produce one or more different phenazine 
derivatives and the spectrum of derivatives may differ significantly among different 
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isolates (3). The production of phenazines has been related to many toxic effects and 
these effects vary depending on the phenazine derivative(s) produced by the microbe (3). 
The toxicity of these phenazine compounds depends largely on their redox activity, 
which determines their ability to generate reactive oxygen species (ROS) (3). For 
example, the toxicity of pyocyanin (1-hydroxy-N-methylphenazine, PCN) produced by 
the opportunistic human pathogen Pseudomonas aeruginosa is primarily the result of the 
creation of ROS. In this process, PCN undergoes aerobic redox cycling to generate 
superoxide and hydrogen peroxide. These ROS induce cell injury in other organisms 
(21). Beyond antibiosis, phenazines also have been shown to serve other roles for the 
producing organism, including acting as electron shuttles and contributing to biofilm 
formation/architecture and rhizosphere competence (3). 
Plant-associated biological control agents produce a diversity of phenazine 
compounds that have been demonstrated to be important for biological control activity. 
For example, phenazine-1-carboxylate (PCA) secreted by Pseudomonas fluorescens 
2-79 contributes to biocontrol activity against fungal phytopathogens such as 
Gaeumannomyces graminis var. tritici, the causal agent of take-all diseases of wheat 
(22). P. chlororaphis 30-84, a biocontrol agent also used to control take-all disease, 
produces three phenazine derivatives, PCA, 2-hydroxy-phenazine-1-carboxylic acid 
(2OHPCA) and 2-hydroxy-phenazine (2OHPZ) (1). The bacterium Pseudomonas 
chlororaphis PCL1391 produces phenazine-1-carboxamide, which plays a role in the 
control of tomato foot and root rot caused by Fusarium oxysporum (23). 
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Given the toxicity of phenazines, a reasonable evolutionary question to address 
is: What mechanism do bacteria producing the phenazines utilize in order to avoid the 
toxic influence of these compounds on themselves? A major mechanism bacteria use to 
protect themselves from the harmful effects of antibiotics is the establishment of a low 
permeability barrier combined with active outward transport (17). Bacteria often 
surround themselves with a low permeability barrier so as to decrease the influx of 
antimicrobials into the cells (9). For example, Gram-positive bacteria have a thick layer 
of peptidoglycan in their cell wall, which not only provides rigidity to the cell but limits 
the diffusion of small diffusible molecules. Although Gram-negative bacteria such as 
Escherichia coli do not have as thick a peptidigycan layer, they protect themselves with 
a second outer membrane, which is composed of lipopolysaccharide (LPS). The outer 
membrane and LPS have been shown to make Gram-negative bacteria more resistant 
than Gram-positive bacteria to lipophilic inhibitors including dyes, detergents, and 
antibiotics (13). Since Pseudomonas species are Gram-negative bacteria, they have this 
type of architecture and method of protection. These same cells also use efflux systems 
to transport antimicrobial compounds that are self-produced or present in the 
environment out of the cell in an energy-dependent way, and thereby become 
intrinsically resistant to many antibiotics (12). 
 There are three major types of efflux systems in Gram-negative bacteria, the 
Major Facilitator (MF) type, the Staphylococcus Multidrug Resistance (SMR) type, and 
the Resistance, Nodulation, Division (RND) type (24). The acriflavine resistance 
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AcrAB-TolC complex in E. coli belongs to the RND type of efflux system (13). RND 
efflux systems are referred to as “proton antiporters,” which means they generate and 
 se a  proton gra ie nt across the membrane “to power effl x”  by “exchanging one H+ ion 
for one  r g molec l e” (25). RND type efflux systems that confer multi-drug resistance 
such as the MexAB-OprM complex also have been studied in Pseudomonas, especially 
P. aeruginosa (26, 27). A comparison of the RND efflux systems in E. coli and P. 
aeruginosa appears below.  
 Analysis of the AcrAB-TolC complex in E. coli revealed that disruption at the 
acr locus caused E. coli cells to be “hyper-susceptible to hydrophobic growth inhibitors 
such as basic dyes, detergents and many antibiotics” (28). Ma et al. (28) analyzed the 
acr locus using functional complementation, and subsequent sequence analysis revealed 
three genes, acrR, acrA, and acrB, expressed on two opposite operons at this locus. This 
organization is similar to the organization of RND genes in P. aeruginosa (fig. 6). 
Furthermore, a time-course study of the accumulation of acriflavine in acrAB+ 
(over-expressing) and acrAB- (mutant) strains firmly proved that acrAB encodes an 
efflux pump (29). A model of the AcrAB-TolC complex is shown in fig. 7. In E. coli, 
acrB encodes a large protein (e.g. containing 1048 amino acids) with 12 putative 
transmembrane α-helices that is believed to be associated with the phospholipid bilayer 
of the inner membrane of the bacterial cell wall (30). The smaller (397 amino acids) 
AcrA is tho ght t o be a periplasmically locate  lipoprotein base  on it s “ n s al  
elongated form, which is consistent with its function in linking or fusing inner and outer 
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membranes” (30). AcrA has been shown to be required for the function of AcrB in intact 
cells (30). A third protein, TolC (506 amino acids), is thought to interact with AcrA to 
form an outer membrane channel and is required for the production of a functional efflux 
pump (31). The gene encoding TolC is not located in the acrAB operon. Ma et al. (32) 
determined that the other gene at the acr locus (but divergently transcribed), the gene 
acrR, encodes a transcription regulator with a helix-turn-helix domain at its N-terminus, 
which serves as a transcription repressor of the acrAB operon (32). Subsequent work 
demonstrated that acrAB is also controlled by global regulators such as MarA, SoxS, and 
Rob (33, 34). In E. coli, the acrEF operon also encodes an RND efflux pump with 
slightly different antimicrobial substrate affinity. AcrE and AcrF are 80 and 88% similar 
to AcrA and AcrB, respectively (32).  
 
 
Figure 6. Comparison of the orientation of the acr locus in E. coli, the acr locus in P. 
chlororaphis 30-84, and the mexAB-oprM operon in P. aeruginosa based on gene annotation. 
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Figure 7. The modeled structure of the AcrAB-TolC complex in E. coli, an RND type efflux 
system, is similar to the MexAB-OprM complex in P. aeruginosa. The green protein depicts the 
inner membrane localized protein corresponding to AcrB in E. coli (or by homology, MexB in P. 
aeruginosa). The blue and red proteins depict the periplasmically localized AcrA and the pore 
forming outer membrane protein TolC in E. coli (or by homology, the MexA and OprM proteins 
in P. aeruginosa) respectively (25). 
Pseudomonas aeruginosa is an important opportunistic pathogen that can 
become resistant to antimicrobials during antibiotic therapy (13). In P. aeruginosa, four 
multi-component, multi-drug resistant RNDs have been identified: MexAB-OprM, 
MexCD-OprJ, MexEF-OprN, and MexXY-OprM (25). These RNDs have the same 
three-protein structure as described for the AcrAB-TolC RND shown in fig. 7. Of these 
four RND systems, the MexAB-OprM is most similar to the AcrAB-TolC system of E. 
coli. It was previously reported that MexA has 71% similarity with AcrA, MexB has 
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83% similarity with AcrB, and OprM has 35% similarity with TolC (25). Comparing the 
4 RNDs, MexB, MexD, MexF and MexY are predicted to have high structural homology 
to the inner membrane protein AcrB. Similarly, structural homology is predicted for the 
MexA, MexC, MexE, MexX and the periplasmically localized AcrA and for the outer 
membrane proteins OprM, OprJ, OprN, OprM and TolC (35).  
The organization of the genes encoding these RND efflux systems is also similar 
among species (fig. 6). Typically, the genes are organized as an operon such that the 
gene encoding the periplasmic localized protein is located adjacent to the gene encoding 
the inner membrane protein and these are usually co-transcribed (fig. 6). The gene 
encoding the outer membrane protein is often, but not always located with the other 
genes; exceptions include E. coli acrAB and tolC and P. aeruginosa 
mexXY and oprM (25). A divergently transcribed regulator gene (typically a repressor) is 
usually located adjacent to the gene encoding the periplasmic localized protein. (25) 
 Similar to E. coli, the different RND efflux systems vary in their substrate 
transport affinities, but differences in the regulation of the four RND efflux systems also 
have been observed (36). For example the MexAB-OprM transporter system is 
constitutively expressed at high level in P. aeruginosa wild type (36, 37). In contrast the 
MexCD-OprJ efflux system is not expressed in the P. aeruginosa wild type (38). 
However, expression of MexCD-OprJ occurs by mutation of NfxB, a transcriptional 
repressor. Mutations in the nfxB gene result in overexpression of the RND efflux system 
and increased multidrug resistance in vivo (39). MexEF-OprN is regulated by a 
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transcriptional activator, MexT. The MexT protein appears to be inactive in wild type 
cells and mutations, which can change the protein to an active state, thus causing 
increased expression of the MexEF-OprN efflux system (40). Also, increased expression 
of the mexEF-oprN efflux system and resistance to multiple antibiotics resulted from 
mutations in the mexS gene (41). Unlike other P. aeruginosa efflux systems, mexXY is 
induced by its transporting antibiotic substrates, including amino glycosides, tetracycline 
and erythromycin (36). The expression of MexXY-OprM is repressed by MexZ, a 
member of the TetR family of transcriptional regulators (42). 
Amino acid sequence comparison of the 30-84 acrA and acrB gene products 
revealed that they share 44 and 54% amino acid identity with the E. coli acrA and acrB 
gene products and are predicted to be the same size. Several 30-84 genes (12 genes) are 
annotated as tolC, the best match sharing 47 % amino acid identity with E. coli TolC. 
The 30-84 acr locus is similar in organization to the E. coli acr locus (fig. 6), containing 
acrA and acrB in the same order and not tolC; the RNA-Seq data indicate that similar to 
E. coli, the 30-84 acrA and acrB genes are co-transcribed (Pierson, unpublished). 
However, 30-84 does not have the divergently transcribed transcriptional regulator acrR; 
instead the regulators RpeA/RpeB are co-located and divergently transcribed. The 30-84 
acrA and acrB gene products are most similar to the P.aeruginosa PAO1 proteins MexE 
(36% amino acid identity) and MexF (44% amino acid identify), respectively. 
Although the role of RND systems in drug resistance has been well documented, 
little is known about the mechanisms of phenazine transport or whether an RND system 
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may be responsible for phenazine transport, as hypothesized in this study. The possible 
role of an AcrAB-like transporter in phenazine export was hypothesized by Girard et al. 
(43). Working with Pseudomonas chlororaphis PCL139, they showed that Pip, a TetR 
type transcriptional regulator similar to AcrR controls the production of 
phenazine-1-carboxamide (PCN) via the regulation of the quorum sensing system 
PhzI/PhzR. They hypothesized that Pip may directly regulate the expression of genes 
encoding an efflux pump analogous to AcrR. They further speculated that since PCN is 
similar in structure to N-acylhomoserine lactone (N-AHL) quorum sensing signals, this 
efflux pump may also transport AHLs. The transport system was not identified in this 
study (43). However, it was shown that although the expression of E. coli acrR is under 
the regulation of the molecules secreted by their target pumps, the transcription of pip 
was not influenced by N-AHL signals or PCN. This finding suggests that if indeed an 
RND system functions in phenazine transport in their system, Pip may not be the 
transport regulator or it may not regulate the transport system in a manner analogous to 
AcrR. Similar to P. chlororaphis PCL139, the quorum sensing regulators PhzI and PhzR 
are regulated by Pip in P. chlororaphis 30-84. Based on the interesting speculations of 
Girard et al. (43), I also investigate the role of Pip in the regulation of the acrAB operon 
in 30-84. A model summarizing the phenazine regulon of 30-84 is provided in the 
Discussion. 
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3. MATERIALS AND METHODS  
 
3.1 Bacteria, plasmids, and culture conditions  
Bacterial strains and plasmids used in this study are listed in Table 1. P. 
chlororaphis 30-84 and mutant derivatives were grown at 28 °C on agar plates or in 
liquid with shaking at 200 rpm in either Luria-Bertani medium (LB), pigment production 
medium D (PPMD) or AB minimal medium supplemented with 2% casamino acids (AB) 
as described previously (4). Escherichia coli was grown at 37 °C in LB. Antibiotics were 
used where appropriate at the following concentrations for E. coli: 50 μg/ml kanamycin 
(KM), 15 μg/ml gentamycin (GM), and 0.001% acriflavine; for P. chlororaphis: 50 
μg/ml KM, 50 μg/ml GM, 0.025% acriflavine, an  100 μg/m l Rifampin (RIF). 
3.2 DNA manipulations and sequence analysis 
Plasmid DNA isolation, cloning, restriction enzyme digestion and T4 DNA 
ligation were performed using standard protocols. Polymerase chain reaction (PCR) was 
carried out using Taq DNA polymerase (either Life Technologies, Carlsbad, CA or 
Promega, Madison, WE) at 94 °C for 10 min, followed by 30 cycles of 95 °C for 30 sec, 
the appropriate annealing temperature for 30 sec and 72 °C for 90 sec (or longer 
depending on gene size), and a final elongation step of 72 °C for 10 min. 
Oligonucliotides and primers are listed in Table 2. Amplicons were initially cloned using 
a TOPO® TA cloning system (Life Technologies). DNA sequencing was performed at 
the DNA Service Center in the Borlaug Center (Texas A&M University, College 
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Station, TX). Transformation of E. coli was carried out using electroporation ready E. 
coli DH5α according to manufacturer protocols (Life Technologies).  
Table 1. Bacterial strains and plasmids used in this study. 
Strain or Plasmid Relevant characteristics Reference or source 
P.chlororaphis   
30-84 Phz+  RifR  wild type Whistler & Pierson 
(10) 
30-84rpeA Phz+  RifRKmR, rpeA : : km Wang et al. (4) 
30-84rpeB Phz+  RifRKmR, rpeB : : km Wang et al. (4) 
30-84pip Phz+  RifRKmR, pip: : Tn5 Wang et al. (4) 
30-84phzR Phz-  RifRKmR, phzR: : Tn5 genomic fusion Pierson et al. (6) 
30-84acrAB Phz+  RifRKmR, harboring Ptac::acrA/acrB This study 
E. coli   
DH5α F- recA1 endA1 hsdR17 supE44 thi-1 gyrA96 
relA1 Δ(argF-lacZYA)I169 
Φ80lacZΔM15 λ– 
Invitrogen Life 
Technology 
HB101 F-  hsdS20(rB
- mB
- ) supE44 recA1 ara14 proA2 
lacY1 galK2 rpsL20 xyl-5 mtl-5 λ–  
Invitrogen Life 
Technology 
Plasmids   
pGT2 pPROBE-GT’: GmR, GFP-based promoter trap 
vector containing a promoterlessgfp gene 
Miller et al. (14) 
pKT2 pPROBE-KT’: KmR, GFP-based promoter trap 
vector containing a promoterlessgfp gene 
Miller et al. (14) 
pKT2Ptac:A/B pKT2 containing the 4.3 kb DNA fragment 
Ptac::acrA/acrB  
This study 
pGT2Ptac:A/B pGT2 containing the 4.3 kb DNA fragment 
Ptac::acrA/acrB  
This study 
pGT2PacrA:A/B pGT2 containing the 4.3 kb DNA fragment 
pacrA::acrA/acrB  
This study 
KmR, ApR, GmR, and RifR, kanamycin, ampicillin, gentamicin, and rifampicin resistance, 
respectively 
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Table 2. Oligonucleotides for gene amplification, cloning verification, and qPCR. 
 Oligonucleotide Sequence (5’– 3’) 
1 F-acrABam GCGGGATCCCAGCATCAGGTCGAGAATCA(BamH1) 
2 R-acrAHind GCGAAGCTTGACAATGTCGGCGAACTCTT(HindIII) 
3 F-acrB CTGATCGGCTTCAACCTGAC 
4 R-acrBHind GCGAAGCTTTTCCAGCCGATGAGAATCTT (HindIII) 
5 F-acrA-kan ATGTCGAAAAACCTGTTTGCGCCGTTCTGCCTGTT
ATTGCTGGCAGCCGCGCTGAGCGCTTGC 
GACCGGGCCTCCACCGCCGAAGAGCAGGCGCCGT
TGGCAAAGCCACGTTGTGTCTCAAAATC 
6 R-acrA-kan GTCCAGTGGTCTGGGCAAGGGGAAGAGGGCTGTC
GTCGATCTGCACCTTTTCGCCCGGACG 
GGCGTGCTGCAGGCCCTCGACGACGATACGGTCG
CCGGCTCTGATTAGAAAAACTCATCG 
7 F-acrB-kan TGCCGCAATTCTTTATCGACCGTCCGGTGTTCGCCT
GGGTGGTCGCCCTGTTTATCCTGCTGG 
CCGGCGCCCTCTCCATCCCGCAGTTGCCGGTGGCG
CACAAAGCCACGTTGTGTCTCAAAATC 
8 R-acrB-kan CGACGCTCACCGCTTTTTTGCCGTTGCGCCTGACC
AGCCTCATCACCACCACGAAGAACAC 
CGGCACGAATACCACCGCCAGGGTCGCGGTGATC
ATGCCTCTGATTAGAAAAACTCATCG 
9 F-acrA ATGTCGAAAAACCTGTTTGC 
10 R-acrA GTCCAGTGGTCTGGGCAAG 
11 F-acrB TGCCGCAATTCTTTATCGAC 
12 R-acrB CGACGCTCACCGCTTTTT 
13 F-TOPO GTAAAACGACGGCCAG 
14 R-TOPO CAGGAAACAGCTATGAC 
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Briefly, 3 µl of electrocompetent cells were diluted in 200 µl of ice water, mixed 
with ~100 µg of plasmid DNA, and cooled on ice 30 min. Electroporation was carried 
out using a Bio-Rad Micro Pulser Electroporator with a cuvette (2 mm gap) according to 
the man fac t r er’s protocol (Bio-Rad Laboratories, Hercules, CA). Cells were then 
grown in 250 µl of S.O.C. Media (Life technologies) for 2 h at 37 °C with shaking and 
then plated on appropriate selection media. Conjugation was carried out via triparental 
mating as described previously (4). Briefly, the donor (Escherichia coli DH5α), the 
helper (E. coli HB101), and the recipient (30-84 derivatives) were grown separately in 
overnight cultures. Equal amounts of each were spotted onto sterile nitrocellulose filter 
on LB agar plates and incubated first at 37 °C for 3 h then at 28 °C for 48 h. The 
resulting cells were resuspended in 5 ml sterile deionized water and 100 µl were spread 
onto LB plates supplemented with RIF to select against E. coli and other antibiotics as 
appropriate. Nucleic acid and amino acid homology searches were conducted using the 
BLAST programs at the National Center for Biotechnology Information (NCBI) 
(http://www.ncbi.nlm.nih.gov/BLAST). P. chlororaphis (aureofaciens) 30-84 draft 
genomic sequence is available in GenBank (Genbank NZ_CM001559.1). The P. 
chlororaphis 30-84) biosynthetic operon contains seven conserved biosynthetic genes 
phzXYFABCD (according to the original nomenclature, (44, 45), which correspond to  
phzABCDEFG (according to the P. fluorescens nomenclature). Here I use the P. 
chlororaphis nomenclature to conform to the original literature.  
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3.3 Generation of vectors for the constitutive expression of acrA/acrB 
The sequences flanking the acrA (Pchl3084-3226) and acrB (Pchl3084-3227) 
genes were used to design primers to amplify these genes, including the promoter and 
ribosome binding site preceding acrA. The primer pairs F-acrABam and R-acrAHind 
were used to amplify a region of the 30-84 chromosome starting 300 nt upstream of the 
ATG start and a ~1 kb portion of the acrB gene containing a unique XhoI site within the 
gene. The F-acrB and R-acrBHind primers were used to amplify 80 bp upstream of the 
unique XhoI site in acrB and 300 nt downstream of the acrB stop codon. By adding 
appropriate restriction enzyme sequences to the primers, the acrA amplicon included 
BamHI and Hin II I restriction enzyme sites at the 3’ an  5’  en s , respectively, and the 
acrB amplicon included a HindIII restriction enzyme site at the 5’ en . The acrA gene 
was subcloned into the multiple cloning site of pUC19 using BamHI and HindIII. The 
acrB gene was then subcloned into pUC 19 containing acrA using XhoI and HindIII. The 
BamHI-acrA/acrB-HindIII fragment was then cloned separately into both KT2 and GT2. 
Prior to insertion of the acrA/acrB fragment the Ptac promoter was inserted separately 
into both KT2 and GT2 at the EcoRI-BamHI site. The final plasmids were designated 
pKT2Ptac:A/B and pGT2Ptac:A/B, respectively. In order to observe the regulation of 
the acrA promoter in the 30-84 rpeB mutant, the BamHI-acrA/acrB-HindIII fragment 
was cloned into GT2 without Ptac such that gene expression was driven by the acrA 
promoter. This plasmid was designated pKT2pacrA:A/B. Plasmids were confirmed by 
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restriction enzyme analysis and partial sequencing and then conjugated into 30-84 and 
appropriate mutant derivatives. 
3.4 Effect of acrA/acrB on resistance to acriflavine and other antimicrobials 
E.coli and 30-84 containing either pKT2Ptac:A/B or KT2 with no insert were 
grown with shaking in LB supplemented with 50 μg/ml KM to an optical density of 0.8 
at 620 nm. E. coli and 30-84 were grown in 37 °C and 28 °C, respectively. Cells were 
collected via centrifugation and resuspended in fresh medium. These cultures were used 
to inoculate (1:100) LB liquid medium, supplemented with acriflavine at a concentration 
of 0.01% for E. coli and 0.025% for P. chlororaphis, respectively.  The OD620 were 
measured after incubation for 14 h.  
 For the other antimicrobials, overnight cultures were prepared in the same way 
and used to inoculate broth containing antibiotics at a rate of 1:100.  A dilution series 
(twofold) of each antibiotic was prepared at the following concentrations for E.coli: 
(0.25, 0.50. 1, 2, 4, 8, 16 μg/ml) an  30 -84 (2, 4, 8, 16, 32, 64, 128 μg/ml). Cell growth, 
measured by OD620, was assayed after 16 h shaking (200 rpm). Data were reported as the 
minimal inhibition concentration (MIC), e.g. the lowest concentration at which bacterial 
growth was negative. An OD620 of less than 0.05 was considered to be negative growth. 
For E. coli, antibiotics tested included carbenicillin, chloramphenicol, piperacillin, and 
tetracycline and for 30-84 included the same antibiotics plus gentamicin, nalidixic acid, 
and polymixin B. Antibiotics were obtained from Sigma-Aldrich (St. Louis, MO) and 
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Amresco (Solon, OH). All assays were conducted with 3 replicates and repeated at least 
twice. 
3.5 Effect of acrA/acrB on growth and phenazine production and transport 
P. chlororaphis 30-84 and derivatives each containing either pGT2Ptac:A/B or 
GT2 with no insert were grown overnight (14 to 18 h) in AB, LB or PPMD broth to late 
exponential phase and adjusted to an OD620 of 1.8. Supernatants were collected after 
centrifugation (3250 x g) for 15 min. The supernatants were acidified to pH 2 with 
concentrated HCl. Total phenazines were extracted twice with an equal volume of 
benzene for 1 h. The benzene phase was collected and evaporated under air. Dried 
phenazines were dissolved in 0.1 N NaOH and quantified by UV-visible spectroscopy 
using 0.1 N NaOH as the blank. Phenazine extraction was confirmed via UV visible 
spectra (200-600 nm). Phenazines were quantified at OD367.  All assays were conducted 
with 3 replicates and repeated at least twice.  
 For analysis of growth curves, treatments were grown and adjusted to the same 
optical density as above. Fresh cultures were inoculated (1:1000) and measurements 
were taken every 1 to 3 h during the exponential phase of growth (between 5 h and 10 h). 
Additional measurements at 25 h and 30 h confirmed that the cultures had entered 
stationary phase. At each time point, samples were collected and phenazines extracted as 
above. All assays consisted of three independent replicate cultures and the assay was 
repeated twice.  
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3.6 Demonstration that AcrA and AcrB function in phenazine transport in E. coli 
E. coli containing either pKT2Ptac::acrA/acrB or KT2 with no insert were grown 
over night with shaking in LB s ppl emente  wit h 50 μg/ml KM to an optical  ens ity of 
1.2 at OD620. These cultures were then used as inoculum for the growth curves; 
inoculum was added to fresh LB supplemented with 50 μg/ml KM (1:100 dilution) 
amended with total phenazines (prepared as above in 0.1N NaOH at a concentration of 
800 μg/ml) or without phenazines. The pH was adjusted to ~7 using 0.1 N HCl. Bacterial 
growth rate (measured as OD620) was measured every two hour. All assays consisted of 
three independent replicate cultures and the assay was repeated twice. 
3.7 Effect of acrA/acrB on pathogen inhibition  
Overnight cultures of 30-84 containing either pKT2Ptac:A/B or KT2 with no 
insert were grown and 15 μl were spotted onto LB plates amended with 0.5 % potato 
dextrose agar. After 2 days of growth at 28 °C, a 5 mm plug of G. graminis was placed 
on the center of the plates. After 4 days, zones of inhibition defined as the distance 
between the edge of the bacterial colony and the fungal mycelium, were measured. 
Measurements were taken on three replicate plates per assay and one representative 
experiment is presented. The experiment was repeated three times with similar results. 
3.8 Generation of the acrA mutant 
An AcrAB deficient mutant will be generated by replacing most of the coding 
sequence of acrA with a kanamycin resistance cartridge (except for the first and last 100 
nt). Because AcrA is required for the formation of a functional AcrAB-TolC RND efflux 
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system in E. coli, it is likely that mutation of acrA will completely disrupt the RND 
system in 30-84. If necessary, I will create a acrA/acrB double mutant. Mutations will be 
created by replacing the target genes in the bacterial chromosome with a recombination 
fragment containing a kanamycin (Km) cassette flanked at both ends by 100 nts with 
sequence homology to both ends of the acrA gene (see fig. 5). When the recombination 
fragment is transformed into the bacterial cell, the replacement of the acrA gene in the 
chromosome with the kanamycin cartridge occurs via homologous recombination. As 
described by Lesic and Rahme (46), the rate of homologous recombination can be 
improved via the introduction of the RedS plasmid (containing the Red operon from 
bacteriophage lambda), which causes recombination events to occur at a high frequency; 
the Red operon is under the control of an arabinose-inducible promoter. Deletions can be 
confirmed via PCR using combinations of the primers F-acrA and R-acrA, F-acrB and 
R-acrB and internal primer pairs, km1 and km2 of the kanamycin gene (Table 1). 
 Several steps of the process have been completed. The first step was to make 
the recombination fragment using PCR with pUC4K as template for the kanamycin 
resistance gene. The recombination fragment consists of a kanamycin cassette under the 
control of its own promoter, flanked at each end by 100 nt with sequence homology to  
acrA. The 5’en s of the forward and reverse primers used for the generation of the 
recombination fragment contained 100 nt with sequence homology to the first 100 bases 
or the last 100 bases of the acrA gene, respectively, whereas the 3’ en  of the forwar  
and reverse primer contained 20 bases with sequence homology to the start or end of the 
26 
 
kanamycin resistance gene, respectively (fig. 5). The resulting recombination fragment 
was cloned into the TOPO TA vector (Life Technologies). 
 The recombination fragment was introduced into P. chlororaphis via a two-step 
process. First, the RedS plasmid (pUCP18-RedS, Table 1) was transformed into P. 
chlororaphis 30-84 wild type via electroporation. Then the recombination fragment was 
transformed into strain P. chlororaphis 30-84 (pUCP18-RedS) via electroporation. For 
the second transformation, P. chlororaphis 30-84 (pUCP18-RedS) was grown in LB 
broth at 26 °C overnight, then reinoculated into LB liquid medium containing 0.1 % 
arabinose (1: 100) to insure expression of the Red operon and cultures were grown to a 
final OD620 of 0.6. Cells in exponential phase were collected to make competent cells. 
Transformants were plated on LB supplemented 50 μg/ml KM. 
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4. RESULTS 
 
In this study, a genetic approach consisting of constitutive gene expression and 
gene mutation studies was used to evaluate the hypotheses that the P. chlororaphis 
30-84 AcrA and AcrB proteins function as an RND type transporter capable of 
conferring multi-drug resistance and transporting phenazines.  
4.1 Constitutive expression of acrA/acrB enhanced RND-type transporter activities 
 For the constitutive gene expression studies, the 30-84 acrA/acrB genes were 
PCR amplified and cloned into either plasmid KT2 or GT2 behind the constitutive 
promoter Ptac, a modified lac operon promoter. Both plasmids KT2 and GT2, differing 
only in the antibiotic resistance genes they contain, replicate and are maintained with 
antibiotic selection in E. coli and are maintained without selection in 30-84. The 
acrA/acrB containing plasmid KT2Ptac::acrA/acrB was transformed into E. coli via 
electroporation and tested for acriflavine resistance and then conjugated into 30-84. 
Bacterial growth (measured as turbidity at OD620) after 14 hours growth in acriflavine 
was used as an indicator of resistance. Consistent with the hypothesis that the 30-84 
AcrA and AcrB proteins function as an RND transport system, constitutive expression of 
the acrA/acrB genes conferred acriflavine resistance to E. coli (fig. 8A) and enhanced 
acriflavine resistance in 30-84 (fig. 8B) relative to the wild type strains carrying the 
plasmid without an insert. Consistent with the observation that transcript abundances of 
acrA and acrB are higher in 30-84 rpeA mutants and lower in 30-84 rpeB mutants, rpeA 
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mutants were more resistant to acriflavine than the wild type. Overexpression of the 
transport genes in wild type made them as resistant to acriflavin as the 30-84 rpeA 
mutant. As expected the rpeB mutant was highly susceptible to acriflavin (fig. 8B).  
 
Figure 8. Acriflavine resistance assay. A. The assay was conducted using E. coli (E.c.) 
containing the KT2 plasmid with no insert (ni) or with Ptac::acrA/acrB. Strains were grown 14 h 
in LB medium with or without 0.01% acriflavine (which colors the media yellow). Bacterial 
growth (indicated by turbidity) was measured at OD620 (data are means and standard errors of 3 
reps). B. Wild type (WT) P. chlororaphis 30-84 containing the plasmid with no insert (ni) or 
with acrA/acrB and derivatives defective in rpeB or rpeA (each containing the control plasmid) 
were grown overnight in LB, adjusted to equivalent cell densities, and inoculated into LB + 
0.025% acriflavine (the higher concentration colors the media orange). Culture growth at 14 h 
was measured at OD620 (data are means and standard errors of 3 reps).  
To determine whether transcriptional repression of the acrA/acrB genes in the 
rpeB mutant is responsible for the enhanced sensitivity of this derivative to acriflavine, 
extra copies of acrA/acrB driven by either the constitutive promoter (Ptac::acrA/acrB) 
or the native acrA promoter (PacrA::acrA/acrB) were introduced into GT2 (fig. 9). 
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Constitutive expression of acrA/acrB resulted in complete restoration of acriflavin 
resistance in the rpeB mutant. However, consistent with the hypothesis that acrA/acrB is 
regulated transcriptionally by RpeB, additional copies of acrA/acrB behind the native 
acrA promoter resulted in substantially lower acriflavine resistance.  
 
Figure 9. Acriflavine resistance assay demonstrating RpeB control of the acrA promotor. Wild 
type (WT) P. chlororaphis 30-84 and the rpeB mutant containing either GT2 plasmid with no 
insert (ni) or with extra copies of acrA/acrB driven by either the native acrA promoter 
(PacrA::acrA/acrB) or the constitutive promoter (Ptac::acrA/acrB). Treatments were grown 
overnight in LB, adjusted to equivalent cell densities, and inoculated into LB + 0.025% 
acriflavine. Culture growth at 14 h was measured at OD620 (data are means and standard errors of 
3 reps). 
 To determine whether genes that regulate phenazine biosynthesis also regulate 
the acrA/acrB genes, the rpeB mutant (deficient in phenazine biosynthesis and transport) 
was complemented with the wild type rpeB gene (should restore both phenazine 
biosynthesis and transport) or pip (a transcriptional regulator required for phenazine 
biosynthesis (4) (fig. 10). As reported by Wang et al., complementation of rpeB with 
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either gene restored phenazine production (4). Cell growth in the presence of acriflavine 
was also measured as a measure of transport activity (OD620). Although 
complementation of the rpeB mutant with wild type rpeB restored transport activity, 
complementation of rpeB with pip did not. Furthermore mutants defective in pip (data 
not shown) or phzR were able to grow in media supplemented with acriflavine as well as 
wild type (fig. 10).  
 
Figure 10. Acriflavine resistance by various 30-84 derivatives. The assay included: wild type 
(WT) P. chlororaphis 30-84 containing the GT2 plasmid with extra copies of acrA/acrB driven 
by the constitutive promoter (Ptac::acrA/acrB), the rpeB mutant derivative complemented with 
either the wild type rpeB(Ptac::rpeB) or pip(Ptac::rpeB) genes or containing only the control 
plasmid (GT2 with no insert), and the phzR mutant derivative (containing the control plasmid). 
Treatments were grown overnight in LB, adjusted to equivalent cell densities, and inoculated 
into LB + 0.025% acriflavine. Culture growth at 14 h was measured at OD620 (data are means 
and standard errors of 3 reps). 
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Previous reports demonstrated that suppression of RND-type efflux systems such 
as the MexAB-OprM system resulted in the cells becoming two- to fourfold more 
susceptible to such antibiotics as aztreonam, tetracycline, carbenicillin, chloramphenicol, 
and novobiocin (40). In order to determine whether acrA/acrB also contributes to 
multi-drug resistance, P. chlororaphis containing either the plasmid KT2 with no insert 
(ni) or with Ptac::acrA/acrB were grown in LB in the presence of increasing (by 
twofold ) concentrations of antimicrobials, as is the standard protocol for assessing the 
minimum inhibitory concentration (MIC). Cell growth (asOD620) was assayed after 16h 
shaking. An OD620 of less than 0.05 was considered to be negative growth. Susceptibility 
was expressed as the MIC (μg/ml), the lowest concentration of an antimicrobial that will 
inhibit the visible growth of a microorganism after overnight (16 h) incubation. 
Constitutive overexpression of acrA/acrB in 30-84 resulted in a four-fold increase in 
resistance to tetracycline and chloramphenicol (Table 3), but not to other antimicrobials 
such as nalidixic acid, gentamicin, or polymyxin b (data not shown).  
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Table 3. Antimicrobial susceptibility (MIC). 
 
aThe concentration (μg/ml) of antimicrobial that inhibited visible growth following overnight 
incubation. 
4.2 Constitutive expression of acrA/acrB enhanced phenazine accumulation in 30-84 
Constitutive expression of acrA/acrB in wild type 30-84 resulted in increased 
amounts of phenazine in culture supernatants compared to wild type containing the 
control plasmid, consistent with acrA and acrB functioning in phenazine transport (Figs. 
11 and 12). To insure that the enhancement in phenazine production due to 
overexpression of acrA/acrB was not simply a result of differential growth, growth 
curves and phenazine production by 30-84 wild type (WT) containing the plasmid KT2 
with no insert (ni) or with Ptac::acrA/acrB were compared. Data confirmed that there is 
no effect of constitutive expression of acrA/acrB on bacterial growth rate. However, 
constitutive over-expression of acrA/acrB resulted in greater phenazine production at 
lower cell densities, compared to the wild type containing the control plasmid (fig. 12). 
 
 
Antibiotics (μg/ml) 30-84 (ni) 30-84 (acrA/B) 
Tetracycline 2a 8 
Chloramphenicol 16 128 
Carbenicillin 2 32 
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Figure 11. The effect of constitutive expression of acrA/acrB on phenazine production in 30-84. 
A. Wild type (WT) P. chlororaphis 30-84 containing the KT2 plasmid with no insert (ni) or with 
Ptac::acrA/acrB and derivatives defective in rpeB or rpeA (each containing the control plasmid) 
were grown 14 h in PPMD medium. B. Bacterial growth was measured at OD620 and all cultures 
exceeded 1.5. C. Culture supernatants were extracted for total phenazines (via acidification and 
benzene). Benzene was evaporated and phenazines were resuspended in 0.1 N NaOH. Phenazine 
extraction was confirmed via UV visible spectra (200-600 nm). D. Phenazines were quantified at 
OD367 (data show means and SE of 3 reps). Data confirm that additional copies of acrA/acrB 
increase phenazine amounts in culture supernatants, consistent with their functioning in 
phenazine transport. 
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Figure 12. Growth curves and phenazine production by 30-84 wild type (WT) containing the 
plasmid KT2 with no insert (orange line) or with Ptac::acrA/acrB (brown line). Cells were 
grown in PPMD medium with shaking at 28 °C. Bacterial growth was measured at OD620. 
Culture supernatants were extracted for total phenazines and quantified at OD367. Data are the 
means of 3 replicates. Standard errors for both measurements were quite small (<0.12) and are 
not shown. 
To determine whether transcriptional repression of the acrA/acrB genes in the 
rpeB mutant is responsible for the reduction in phenazine production compared to wild 
type, extra copies of acrA/acrB driven by either the constitutive promoter 
(Ptac::acrA/acrB) or the native acrA promoter (PacrA::acrA/acrB) were introduced onto 
GT2 (fig. 13). Bacterial strains were grown in PPMD for 16 h to an OD620 of 1.3, and the 
amount of extracted phenazines was measured at OD367. As expected the rpeB mutant 
produced very little phenazine during this time period. Expression of the acrA/acrB 
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genes in trans in the rpeB mutant did not restore phenazine production to wild type 
levels. This finding is consistent with the hypothesis that rpeB regulates both phenazine 
production and transport, e.g. over-expression of acrA/acrB in the rpeB mutant would 
not be expected to restore the wild type phenotype unless other RpeA/RpeB controlled 
traits involved in the regulation of phenazine biosynthesis such as quorum sensing were 
also restored. However, the amount of phenazine produced by ∆rpeB containing 
acrA/acrB (PacrA::acrA/acrB) varied by media type (fig. 14).  
 
Figure 13. Phenazine production by the 30-84 rpeB mutant is not rescued by overexpression of 
acrA/acrB. Wild type (WT) P. chlororaphis 30-84 and the rpeB mutant containing either the 
GT2 plasmid with no insert (ni) or with extra copies of acrA/acrB driven by either the native 
acrA promoter (PacrA::acrA/acrB) or the constitutive promoter (Ptac::acrA/acrB). Bacterial 
strains were grown in PPMD for16 h at 28 °C with shaking to an OD600 of 1.3. Phenazine was 
extracted in benzene and the amount of phenazine was measured at OD367. Data points represent 
means ± standard errors of three replicates.  
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Figure 14. Phenazine production in different media. Phenazine production by the wild type and 
the rpeB mutant containing either the control plasmid (GT2) or constitutively expressing the 
acrA/acrB (e.g. containing the insert Ptac::acrA/acrB). For maximal phenazine production 
bacteria were grown in different media (AB, LB, or PPMD) for 48 h at 28 °C with shaking. 
Phenazine was extracted in benzene and the amount of phenazine was measured at OD367. Data 
points represent means ±standard errors of three replicates. Similar results were obtained in two 
independent experiments. 
4.3 Demonstration that AcrA and AcrB function in phenazine transport 
Total phenazine extracted from 30-84 was inhibitory to the growth of E. coli 
starting at a concentration of ~300 µg/ml (data not shown) and became more inhibitory 
as the concentration was increased to ~800 µg/ml (fig. 15 A, B). For this assay, the 
growth of E.coli with the plasmid containing PacrA::acrA/acrB was compared to the  
growth of E. coli with the control plasmid in LB containing 800 µg/ml phenazine. In the 
absence acrA/acrB, growth was significantly decreased, although after 16 h the growth  
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of E. coli with and without acrA/acrB was equivalent. In the absence of phenazines, the 
E. coli with and without acrA/acrB grew at the same rate, indicating that the increase in 
growth in the presence of phenazines was due entirely to the ability to transport 
phenazines. Importantly, the total phenazine extract contained a mixture of 
non-hydroxylated and hydroxylated phenazines (e.g., PCA, 2OHPCA, 2OHPHz).  In 
contrast, commercial phenazine (SigmaAldrich) did not inhibit E.coli at a concentration 
of ~300 µg/ml (diluted in DMSO—phenazine was not soluble above this concentration). 
These data are consistent with previous observations that the phenazines produced by 
30-84 can be inhibitory to E. coli (Pierson, unpublished). E. coli expressing 30-84 
acrA/acrB were protected from phenazines as indicated by their ability to grow in 
concentrations of 800 µg/ml as well as E. coli in media without phenazines (fig. 15 B, 
C). The ability to resist inhibition by phenazine demonstrates for the first time that the 
30-84 AcrA and AcrB function in their transport. These results suggest that the native E. 
coli TolC was able to facilitate the formation of a complete transport system.  
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Figure 15. Demonstration that AcrA and AcrB function in the transport of phenazines in E. coli. 
A. Bacterial growth (after 9 h) of E. coli with the control plasmid (first column) or the plasmid 
containing PacrA::acrA/acrB (second column) when grown with 800 µg/ml phenazine or 
without phenazines (third and fourth columns, respectively) as indicated by turbidity. B. Growth 
curve of E. coli with the control plasmid (black line) or the plasmid containing 
PacrA::acrA/acrB (blue line) when grown with 800 µg/ml phenazine. C.  Growth curve of E. 
coli with the control plasmid (black line) or the plasmid containing PacrA::acrA/acrB (blue line) 
when grown without phenazine. 
4.4 Constitutive expression of acrA/acrB in 30-84 results in enhanced pathogen 
inhibition in vitro 
The constitutive expression of acrA/acrB can have important implications for 
biological control activity. As expected earlier and greater production and diffusion of 
phenazines significantly affects the capacity of 30-84 to inhibit fungi under conditions 
where diffusion is limited such as on agar plates. For example inhibition of the fungus  
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G. graminis was greater for 30-84 cells containing copies of acrA/acrB than for cells 
containing the control plasmid (Fig 16).  
 
Figure 16. Fungal inhibition assay. Overnight cultures of wild type 30-84 containing either the 
control plasmid KT2 or the plasmid with Ptac::acrA/acrB were spotted onto LB plates amended 
with 0.5% potato dextrose agar. After 2 days of growth at 28 °C, a 5 mm plug of G. graminis 
was placed in the center of the plates. The zones of inhibition were measured at 4 days 
post-inoculation. Data represent means±standard errors of three replicates. The experiment was 
repeated three times with similar results. 
4.5 Creation of the acrA deletion mutant 
Preliminary studies confirm that the recombination fragment is correctly 
constructed and is now contained within the TOPO TA vector. The fragment has been 
transferred to electrocompetent 30-84 cells via electroporation. Efforts to obtain double 
crossovers have been unsuccessful to date. One possibility for this lack of double 
crossovers is that mutations in phenazine transport may be lethal, however, this 
possibility has not been confirmed. More likely the amount of sequence homologous to 
acrA is to small and longer homology arms on either side of the kanamycin cartridge are 
needed to facilitate efficient production of double crossovers. 
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5. DISCUSSION 
 
 In this study I have demonstrated for the first time that the P. chlororaphis 
30-84 acrA and acrB genes encode an RND type efflux system that is capable of 
transporting phenazines and other antimicrobials. This was demonstrated using a 
constitutive gene expression approach in which a fragment containing the 30-84 genes 
annotated as acrA and acrB were cloned behind the constitutive promoter Ptac and the 
genes expressed on a very stable plasmid in trans in either E. coli DH5 α or 30-84. This 
experiment confirmed that constitutive expression of acrA/acrB conferred acriflavine 
resistance to E. coli and increased acriflavine resistance in 30-84. Constitutive 
overexpression of the genes in 30-84 also increased resistance to other antimicrobials. 
Importantly, constitutive expression of acrA/acrB enhanced the growth of E. coli in the 
presence of ~300-800 µg of total phenazines extracted from 30-84, demonstrating the 
function of the AcrA and AcrB proteins in phenazine transport. 
 As in other studies, the present results showed that expression of the 
periplasmically located protein (AcrA) and the inner membrane protein (AcrB) were 
sufficient to incorporate efficient acriflavine transport function in E. coli. Expression of 
the third component of the RND system, the outer membrane protein (TolC), was not 
necessary for efficient transport function (32). These results suggest that the endogenous 
E. coli TolC protein or another outer membrane homolog is sufficient to complement 
this deficiency. This speculation is supported by the observation that the outer membrane 
41 
 
protein is typically not co-transcribed with the structural genes and often not even 
located close by on the chromosome. Co-transcription suggests that the gene products 
likely function together. Previous reports suggest that in the absence of the AcrA and 
AcrB proteins, the E. coli TolC protein may still be found in the outer membrane, 
indicating it is not specifically a component of the AcrAB efflux system (47). 
Furthermore, within the genome there are many genes annotated as encoding outer 
membrane proteins that might serve as a substitute. The complete lack of acriflavine 
resistance in E. coli DH5α was somewhat surprising given that the AcrAB-TolC system 
was first described in E. coli. One hypothesis is that E. coli DH5α, a laboratory 
derivative of K12, lacks either acrA or acrB, or both, or they are not functional or not 
expressed. This deficiency was useful for demonstrating that protection from phenazines 
via the 30-84 AcrAB transport system was not likely due to a native AcrAB system.  
 The data support the hypothesis that the 30-84 AcrAB system is capable of 
transporting a diversity of antimicrobials with a spectrum similar to that observed for the 
AcrAB-TolC system in E. coli (28). For example, clear differences in MIC for 
tetracycline, chloramphenicol and carbenicillin were observed between wild type P. 
chlororaphis transformed with the control plasmid and wild type P. chlororaphis 
constitutively overexpressing acrA/acrB. Also similar to the AcrAB-TolC system in E. 
coli, no enhancement in growth due to constitutive overexpression of acrA/acrB in the 
presence of gentamicin and polymixin B was observed. However, in contrast to results 
with E. coli, the 30-84 AcrAB system did not confer resistance to nalidixic acid. It has 
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been shown that substrate binding to AcrB is largely responsible for substrate affinity 
(25). This may depend on the partial binding of the substrate to the inner membrane first 
and then the AcrB protein. A possible explanation for this difference in substrate affinity 
or transport efficiency between E. coli and 30-84 may be that despite the structural 
similarity of the AcrA and AcrB proteins, there may be differences in the AcrB proteins 
(or both AcrA and AcrB), particularly at the binding sites (25). Furthermore, it is 
possible that the 30-84 AcrAB system may have a higher affinity or transport efficiency 
for phenazines than other RND systems. This hypothesis needs further testing. Future 
research could include expressing other RND pumps in E. coli DH5α an  c omparing 
phenazine transport activity. It is interesting to note that many Gram negative bacteria 
like E. coli and Pseudomonas have multiple demonstrated or putative (based on protein 
homology) RND efflux systems. In spite of high protein homologies, differences in the 
AcrA and AcrB components may confer differences in substrate affinity. It was 
previo sly s  ggest e  that “environmental” species are more likely to have more effl x 
systems, presumably because they are exposed to a greater diversity of antimicrobial 
substances (48).   
 Despite the similarity in the organization between the 30-84 acrA and acrB 
genes and the homologs in other RND systems, the regulation of these genes in 30-84 is 
somewhat unique. For many of the RND efflux systems, a transcriptional regulator, 
typically a repressor is located adjacent to and divergently transcribed from the genes 
encoding the structural components. For example, in E. coli, acrR is located upstream of 
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acrA and acrB and this gene represses the expression of acrA and acrB. Mutations in 
acrR cause E. coli to become more resistant to AcrAB-transported antibiotics (29). In 
Pseudomonas, mexR, nfxB, and mexZ are transcriptional regulators (repressors) located 
upstream of the mexAB, mexCD, and mexXY operons, respectively (36, 39, 41). The 
operon mexEF is regulated by two proteins immediately adjacent to the operon, mexS, a 
transcriptional repressor, and mexT, a transcriptional activator via a somewhat 
complicated interaction (41). In contrast to all of these systems, rpeB (the transcriptional 
regulator) and rpeA (a sensor kinase) (composing a two component regulatory system) 
are immediately adjacent and divergently transcribed from the 30-84 acrAB operon.  
 The presence of a two component regulatory system upstream of the genes 
encoding the structural proteins has been observed previously in Acinetobacter 
baumannii, where the AdeABC RND efflux system is regulated by the two component 
system AdeS/AdeR (49). The organization of the locus is the same as is found in 30-84. 
In this system, mutation in adeS (the sensor kinase) causes an increase in susceptibility 
to antibiotics (e.g. loss of transporter function); the effect mutation in adeR (the response 
regulator) could not be determined (polar mutation). However, substitutions in the AdeS 
and AdeR proteins resulted in constitutive expression of the efflux system and antibiotic 
resistance (49). Marchand et al. (49) postulated that the histidine kinase, AdeS, like most 
histidine kinase proteins, had the capacity to both phosphorylate (kinase activity) and 
dephosphorylate (phosphorylase activity) the AdeR transcriptional regulator. However 
net kinase activity typically resulted in activation of the transcriptional regulator. 
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Mutation of either component resulted in the loss of kinase activity, loss of activation of 
the transport system, and thus increased susceptibility. Point mutations in the specific 
receiver domains resulted in loss of phosphorylase activity, constitutive kinase activity, 
and increased resistance. However, the regulatory situation is slightly different for 30-84, 
where mutation in rpeA causes up-regulation of the acrAB operon and mutation in rpeB 
or both genes causes down regulation of the acrAB operon (unpublished data). It was 
postulated that phosphorylated RpeB promotes the expression of pip and the quorum 
sensing genes phzI/phzR (4). RpeA, a transmembrane protein is thought to modulate the 
ratio of phosphorylated and non-phosphorylated RpeB in response to environmental 
conditions, thus modulating phenazine biosynthesis in response to those same 
environmental states. According to Wang et al. (4), “the level of active, phosphorylate  
RpeB is possibly controlled by RpeA or other small phosphor-donors such as acetyl 
phosphate.” As expected loss of the transcriptional activator RpeB results in loss of 
phenazine biosynthesis and transport. Interestingly, loss of RpeA results in the loss of 
the ability to dephosphorylate RpeB and thus loss of the ability to modulate the 
expression of phenazine biosynthesis and transport in response to environmental 
conditions.  
 The present results suggest that the regulation of the biosynthesis and transport 
of phenazines should be coordinately regulated (Fig 17). Phenazine biosynthesis is 
regulated directly by the quorum sensing system PhzI/PhzR. These genes are, in turn, 
regulated in a hierarchical way by Pip and RpeB, respectively, although the need for this 
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hierarchal regulation is not well understood; it may be related to observations that 
sub-inhibitory levels of phenazine may serve as a signal that promotes further 
biosynthesis whereas higher levels may promote a stress response (50). Based on the 
homology between Pip and AcrR, it was postulated previously that analogous to AcrR, 
Pip might regulate the expression of genes encoding an efflux pump (43). In the present 
study it was shown that the acrAB operon is transcriptionally regulated by RpeB, but is 
not controlled by Pip or PhzR. Thus, RpeB links both phenazine biosynthesis and 
transport. It is interesting to consider why such an elaborate mechanism for linking both 
functions exists, e.g. why not transcriptionally regulate both the phz biosynthetic operon 
and the acrAB operon by quorum sensing? The hypothesis is that AcrA/AcrB function in 
the transport of a diversity of antimicrobials of which phenazine is just one example. 
Thus direct regulation of the AcrAB efflux system occurs via a membrane bound sensor 
kinase capable of modulating transcriptional regulator activity in response to stress. 
Furthermore, rapid response to environmental stress is likely facilitated by this type of 
regulation because RpeA has both kinase and phosphorylase activity, e.g. control is 
modulated by the ratio of active to non-active transcriptional regulator (e.g. 
phosphorylated to dephosphorylated RpeB) rather than by an increase in the amount of 
the regulator (e.g. via transcription and translation). A model describing this proposed 
interconnected regulatory system for the control of phenazine biosynthesis and transport 
is shown in Figure 17. 
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Figure 17. Proposed model of RpeA/RpeB regulation of phenazine biosynthesis and transport. 
The phenazine locus contains four operons: the phenazine biosynthetic genes phzXYFABCD 
encode enzymes for synthesis of PCA, phzO encodes an enzyme responsible for producing the 
hydroylated phenazines 2OHPCA and 2OHPHZ, phzI encodes a signal synthase responsible for 
the production of an AHL signal, and phzR encodes a transcriptional regulator that dimerizes 
with the AHL signal to recruit polymerase to the phzXYFABCD operon and initiate expression. 
The quorum sensing system PhzI/PhzR is hierarchically regulated by Pip, a transcriptional 
regulator, and RpeB. RpeA/RpeB compose a two component signal transduction system. RpeB 
is a transcriptional regulator that is active when phosphorylated. RpeA is a membrane bound 
sensor kinase that is capable of kinase and phosphorylase activity in response to environmental 
stimuli. Active phosphorylated RpeB positively regulates the phenazine biosynthetic regulatory 
pathway. It also positively regulates the transcription of acrA and acrB which are co-transcribed. 
acrB encodes an inner membrane protein which together with AcrA (a periplasmically located 
protein) and TolC (an outer membrane protein), forms a channel that functions like RND type 
proton antiporters (25). Transported substrates are believed to bind to the inner membrane and 
then the binding site on AcrB. It is believed that one substrate molecule is transported for every 
proton. 
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The study of phenazines is important due to their role in effective biological 
control activity. The present study was initiated with the hypothesis that the AcrAB 
efflux system was a phenazine transporter, and if so, it should be coordinately regulated 
with biosynthesis in order to protect the cells from the toxic effects of phenazines. 
However, I discovered it is capable of transporting diverse antimicrobials. These results 
now suggest that the coordination also may be a defense strategy against other microbes 
that produce antimicrobials. In this scenario, the transport genes that provide resistance 
are coordinately expressed with the production of phenazines. This might be a 
competitive mechanism that may contribute to competence in the plant rhizosphere. 
However this hypothesis needs further testing.  
 Ongoing work is focused on generating a 30-84 AcrA mutant. The first step will 
be to complement the mutant to demonstrate that it is correctly constructed. Once a 
30-84 AcrA mutant is successfully constructed, it will be used to determine the impact of 
loss of the AcrAB efflux system on bacterial fitness. Plans include comparing wild type 
and mutant fitness (measured using bacterial growth curves) in response to various 
antimicrobials or stresses. It is also important to examine fitness on plants. Experiments 
would include introducing the wild type and mutant individually and in mixture in sterile 
and natural soil (e.g. with natural rhizosphere microbes). Finally, it is possible that the 
AcrAB efflux system could be involved in the transport of plant signals or plant 
antimicrobials and so plant-microbe interactions might be altered. The role of plant 
signals might be tested by comparing wild type and mutant chemotactic behavior and the 
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role of antimicrobials could be tested with growth curve assays or root colonization 
assays. 
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6. CONCLUSIONS  
 
This study was initiated based on speculation that P. chlororaphis 30-84 genes annotated 
as homologs to E. coli acrA/acrB genes, might encode an AcrAB-TolC RND efflux 
system. My results demonstrate that constitutive expression of acrA/acrB conferred 
acriflavine resistance to E. coli and increased acriflavine resistance in 30-84, consistent 
with these genes encoding an AcrAB-TolC type efflux system.  
 I tested the hypothesis that similar to the E. coli AcrAB-TolC RND efflux 
system, the 30-84 system would transport a diversity of substrates. Compared to wild 
type, constitutive overexpression of the acrA/acrB genes in 30-84 also increased 
resistance to some antimicrobials but not others, demonstrating that the 30-84 system 
could transport multiple substrates, but has limited substrate affinity or transport 
efficiency. 
 I tested the hypothesis that this efflux system would be capable of transporting 
phenazines based on the similarity in the molecular structure of acriflavin and phenazine. 
Compared to wild type, constitutive expression of acrA/acrB facilitated the growth of E. 
coli in the presence of ~300-800 µg of total phenazines extracted from 30-84, 
demonstrating the function of AcrA and AcrB in phenazine transport. 
 I tested the hypothesis that if intercellular concentration of phenazine served as 
a signal to increase phenazine biosynthesis, constitutive expression of the efflux system 
might result in greater phenazine production and biological control activity. Compared 
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to wild type, constitutive expression of acrA/acrB induced earlier and greater production 
and diffusion of phenazines and significantly affected the capacity of 30-84 to inhibit 
fungi growth. 
 I tested the hypothesis that the RpeA/RpeB two component signal transduction 
system might be involved in the coordinate regulation of phenazine biosynthesis and 
transport. The results showed that RpeB controls both phenazine biosynthesis and 
transport. However the two regulatory pathways are not linked by any regulatory 
intermediates. Constitutive expression of the acrA/acrB genes in trans in a rpeB mutant 
did not rescue phenazine production unless other traits, regulated by RpeA/RpeB, that 
involved the regulation of phenazine biosynthesis such as quorum sensing were also 
restored. Constitutive expression of pip in trans did not restore acriflavine resistance and 
Pip and PhzR mutants were both acriflavine resistant. 
 Finally, the present results outline a path for future studies that may elucidate 
the role of the 30-84 AcrAB efflux system in biological control activity, bacterial fitness, 
rhizosphere competence and competition, and plant-microbial interactions. 
 
 
51 
 
REFERENCES 
 
1. Weller DM, Cook RJ. 1983. Suppression of take-all of wheat by seed treatments 
with fluorescent pseudomonads. Phytopathology. 73: 463-469. doi:10.1094/Phyto- 
73-463. 
2. Zhang Z, Pierson LS. 2001. A second quorum-sensing system regulates cell surface 
properties but not phenazine antibiotic production in Pseudomonas aureofaciens. 
Appl Environ Microbiol. 67: 4305-4315. doi:10.1128/AEM.67.9.4305-4315.2001. 
3. Pierson LS, Pierson EA. 2010. Metabolism and function of phenazines in bacteria: 
impacts on the behavior of bacteria in the environment and biotechnological 
processes. Appl Microbiol Biotechnol. 86: 1659-1670. doi: 10.1007/s00253-010- 
2509-3. 
4. Wang D, Yu JM, Pierson LS, Pierson EA. 2012. Differential regulation of 
phenazine biosynthesis by RpeA and RpeB in Pseudomonas chlororaphis 30-84. 
Microbiology. 158: 1745-1757. doi: 10.1099/mic.0.059352-0. 
5. Chancey ST, Wood DW, Pierson EA, Pierson LS. 2002. Survival of GacS/GacA 
mutants of the biological control bacterium Pseudomonas aureofaciens 30-84 in the 
wheat rhizosphere. Appl Environ Microbiol. 68: 3308-3314. doi:10.1128/AEM.68.7. 
3308-3314.2002. 
6. Pierson LS, Keppenne VD, Wood DW. 1994. Phenazine antibiotic biosynthesis in 
Pseudomonas aureofaciens 30-84 is regulated by PhzR in response to cell density. J 
Bacteriol. 176: 3966-3974. 
7. Price-Whelan A, Dietrich LE P, Newman DK. 2006. Rethinking 'secondary' 
metabolism: physiological roles for phenazine antibiotics. Nat Chem Biol. 2: 71-78. 
doi:10.1038/nchembio764. 
8. Britigan BE, Roeder TL, Rasmussen GT, Shasby DM, McCormick ML, Cox CD. 
1992. Interaction of the Pseudomonas aeruginosa secretory products pyocyanin and 
pyochelin generates hydroxyl radical and causes synergistic damage to endothelial 
cells. Implications for Pseudomonas-associated tissue injury. J. Clin. Invest. 90: 
2187-2196. doi: 10.1172/JCI116104. 
9. Van Bambeke F, Balzi E, Tulkens PM. 2000. Antibiotic efflux pumps. Biochem 
52 
 
Pharmacol. 60: 457-470. doi: 10.1016/S0006-2952(00)00291-4. 
10. Whistler CA, Pierson LS. 2003. Repression of phenazine antibiotic production in 
Pseudomonas aureofaciens strain 30-84 by RpeA. J. Bacteriol. 185: 3718-3725. doi: 
10.1128/JB.185.13.3718-3725.2003. 
11. Nakamura H. 1965. Gene-controlled resistance to acriflavine and other basic dyes 
in Escherichia coli. J. Bacteriol. 90: 8-14. 
12. Nikaido H. 1994. Prevention of drug access to bacterial targets: permeability 
barriers and active efflux. Science. 264: 382-388. doi: 10.1126/science.8153625. 
13. Nikaido H. 1996. Multidrug efflux pumps of gram-negative bacteria. J. Bacteriol. 
178: 5853. 
14. Miller WG, Leveau JHJ, Lindow SE. 2000. Improved gfp and inaZ broad-host- 
range promoter-probe vectors. Mol Plant Microbe Interact. 13: 1243-1250. doi: 
10.1094/MPMI.2000.13.11.1243 
15. Lugtenberg B, Kamilova F. 2009. Plant-growth-promoting rhizobacteria. Annu Rev 
Microbiol. 63: 541-556. doi: 10.1146/annurev.micro.62.081307.162918. 
16. Weller DM. 2007. Pseudomonas biocontrol agents of soilborne pathogens: looking 
back over 30 years. Phytopathology. 97: 250-256. doi: 10.1094/PHYTO-97-2-0250. 
17. Raaijmakers JM, Vlami M, De Souza JT. 2002. Antibiotic production by bacterial 
biocontrol agents. Antonie Van Leeuwenhoek. 81: 537-547. doi: 
10.1023/A:1020501420831. 
18. Thomashow LS. 1996. Biological control of plant root pathogens. Curr Opin 
Biotechnol. 3: 343–347. doi: 10.1016/S0958-1669(96)80042-5. 
19. Weller DM. 1988. Biological control of soilborne plant pathogens in the rhizosphere 
with bacteria. Annu Rev Phytopathol. 6: 379-407. doi: 10.1146/annurev.py. 
26.090188.002115. 
20. Gibson J, Sood A, Hogan DA. 2009. Pseudomonas aeruginosa-Candida albicans 
interactions: localization and fungal toxicity of a phenazine derivative. Appl Environ 
Microbiol. 75: 504-513. doi: 10.1128/AEM.01037-08. 
21. Reszka KJ, Xiong Y, Sallans L, Pasula R, Olakanmi O, Hassett DJ, Britigan BE. 
53 
 
2012. Inactivation of the potent Pseudomonas aeruginosa cytotoxin pyocyanin by 
airway peroxidases and nitrite. Am J Physiol Lung Cell Mol Physiol. 302: 1044- 
1056. doi: 10.1152/ajplung.00172.2011. 
22. Thomashow LS, Weller DM, Bonsall RF, Pierson LS. 1990. Production of the 
antibiotic phenazine-1-carboxylic acid by fluorescent Pseudomonas species in the 
rhizosphere of wheat. Appl Environ Microbiol. 56: 908-912. 
23. Chin-A-Woeng TFC, Bloemberg GV, Mulders IHM, Dekkers LC, Lugtenberg 
BJ. 2000. Root colonization by phenazine-1-carboxamide-producing bacterium 
Pseudomonas chlororaphis PCL1391 is essential for biocontrol of tomato foot and 
root rot. Mol Plant Microbe Interact. 13: 1340-1345. doi: 10.1094/MPMI.2000.13. 
12.1340 
24. Lewis K. 1994. Multidrug resistance pumps in bacteria: variations on a theme. 
Trends Biochem Sci. 19: 119-123. doi: 10.1016/0968-0004(94)90204-6. 
25. Piddock LJV. 2006. Clinically relevant chromosomally encoded multidrug 
resistance efflux pumps in bacteria. Clin Microbiol Rev. 19: 382-402. doi: 
10.1128/CMR.19.2.382-402.2006 
26. Akama H, Kanemaki M, Yoshimura M, Tsukihara T, Kashiwagi T, Yoneyama 
H, Narita S, Nakagawa A, Nakae T. 2004. Crystal structure of the drug discharge 
outer membrane protein, OprM, of Pseudomonas aeruginosa dual modes of 
membrane anchoring and occluded cavity end. J Biol Chem. 279: 52816-52819. doi: 
10.1074/jbc.C400445200 
27. Akama H, Matsuura T, Kashiwagi S, Yoneyama H, Narita S, Tsukihara 
T, Nakagawa A, Nakae T. 2004. Crystal structure of the membrane fusion protein, 
MexA, of the multidrug transporter in Pseudomonas aeruginosa. J Biol Chem. 279: 
25939-25942. doi: 10.1074/jbc.C400164200 
28. Ma D, Cook DN, Hearst JE, Nikaido H. 1994. Efflux pumps and drug resistance in 
gram-negative bacteria. Trends Microbiol. 2: 489-493. doi: 10.1016/0966- 
842X(94)90654-8. 
29. Ma D, Alberti M, Lynch C, Nikaido H, Hearst JE. 1996. The local repressor AcrR 
plays a modulating role in the regulation of acrAB genes of Escherichia coli by 
global stress signals. Mol Microbio. 19: 101-112. doi: 10.1046/j.1365-2958.1996. 
357881.x 
54 
 
30. Zgurskaya HI, Nikaido H. 1999. Bypassing the periplasm: reconstitution of the 
AcrAB multidrug efflux pump of Escherichia coli. Proc Natl Acad Sci. 96: 
7190-7195. doi: 10.1073/pnas.96.13.7190 
31. Fralick JA. 1996. Evidence that TolC is required for functioning of the Mar/AcrAB 
efflux pump of Escherichia coli. J Bacteriol. 178: 5803-5805. 
32. Ma D, Cook DN, Alberti M, Pon NG, Nikaido H, Hearst JE. 1993. Molecular 
cloning and characterization of acrA and acrE genes of Escherichia coli. J Bacteriol. 
175: 6299-6313. 
33. Skarstad K, Thöny B, Hwang D S, Kornberg A. 1993. A novel binding protein of 
the origin of the Escherichia coli chromosome. J Biol Chem. 268: 5365-5370. 
34. Cohen S P, Hächler H, Levy S B. 1993. Genetic and functional analysis of the 
multiple antibiotic resistance (mar) locus in Escherichia coli. J Bacteriol. 175: 
1484-1492. 
35. Magnet S, Courvalin P, Lambert T. 2001. Resistance-nodulation-cell division-type 
efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii 
strain BM4454. Antimicrob Agents Chemother. 45: 3375-3380. doi: 10.1128/AAC. 
45.12.3375–3380.2001. 
36. Masuda N, Sakagawa E, Ohya S,  Gotoh N, Tsujimoto H, Nishino T. 2000. 
Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux 
pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 44: 3322-3327. 
doi:10.1128/AAC.44.12.3322-3327.2000 
37. Poole K, Krebes K, McNally C, Neshat S. 1993. Multiple antibiotic resistance in 
Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol. 
175: 7363-7372. 
38. Chuanchuen R, Beinlich K, Hoang TT,  Becher A, Karkhoff-Schweizer 
RR, Schweizer HP. 2001. Cross-resistance between triclosan and antibiotics in 
Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a 
susceptible mutant strain to triclosan selects nfxB mutants overexpressing 
MexCD-OprJ. Antimicrob Agents Chemother. 45: 428-432. doi: 10.1128/AAC. 
45.2.428-432.2001. 
39. Poole K, Gotoh N, Tsujimoto H, Zhao Q, Wada A, Yamasaki T, Neshat 
55 
 
S, Yamagishi J, Li XZ, Nishino T. 1996. Overexpression of the mexC-mexD-oprJ 
efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. 
Mol Microbio. 21: 713-725. doi: 10.1046/j.1365-2958.1996.281397.x. 
40. Maseda H, Uwate M, Nakae T. 2010. Transcriptional regulation of the 
mexEF-oprN multidrug efflux pump operon by MexT and an unidentified repressor 
in nfxC-ype mutant of Pseudomonas aeruginosa. FEMS Microbiol Lett. 311: 36-43. 
doi: 10.1111/j.1574-6968.2010.02063.x. 
41. Uwate M, Ichise Y, Shirai A, Omasa T, Nakae T, Maseda H. 2013. Two routes of 
MexS-MexT-mediated regulation of MexEF-OprN and MexAB-OprM efflux pump 
expression in Pseudomonas aeruginosa. Microbiol Immunol. 57: 263-272. doi: 
10.1111/1348-0421.12032. 
42. Matsuo Y, Eda S, Gotoh N, Yoshihara E, Nakae T. 2004. MexZ-mediated 
regulation of mexXY multidrug efflux pump expression in Pseudomonas aeruginosa 
by binding on the mexZ-mexX intergenic DNA. FEMS Microbiol Lett. 238: 23-28. 
doi: 10.1016/j.femsle.2004.07.010. 
43. Girard G, Barends S, Rigali S, Van Rij ET, Lugtenberg BJ, Bloemberg GV. 
2006. Pip, a novel activator of phenazine biosynthesis in Pseudomonas chlororaphis 
PCL1391. J Bacteriol. 188: 8283-8293. doi: 10.1128/JB.00893-06. 
44. Pierson LS, Gaffney T, Lam S, Gong F. 1995. Molecular analysis of genes 
encoding phenazine biosynthesis in the biological control bacterium Pseudomonas 
aureofaciens 30–84. FEMS Microbiol Lett. 134: 299-307. doi: 10.1111/j.1574- 
6968.1995.tb07954.x. 
45. Mavrodi DV, Blankenfeldt W, Thomashow LS. 2006. Phenazine Compounds in 
Fluorescent Pseudomonas Spp. Biosynthesis and Regulation*. Annu Rev 
Phytopathol. 44: 417-445. doi: 10.1146/annurev.phyto.44.013106.145710. 
46. Lesic B, Rahme LG. 2008. Use of the lambda Red recombinase system to rapidly 
generate mutants in Pseudomonas aeruginosa. BMC Mol Biol. 9: 20. doi: 
10.1186/1471-2199-9-20. 
47. Aono R, Tsukagoshi N, Yamamoto M. 1998. Involvement of outer membrane 
protein TolC, a possible member of the mar-sox regulon, in maintenance and 
improvement of organic solvent tolerance of Escherichia coli K-12. J Bacteriol.180: 
938-944. 
56 
 
48. Piddock LJV. 2006. Multidrug-resistance efflux pumps? not just for resistance . Nat 
Rev Microbiol. 4: 629-636. doi: 10.1038/nrmicro1464. 
49. Marchand I, Damier-Piolle L, Courvalin P, Lambert T. 2004. Expression of the 
RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the 
AdeRS two-component system. Antimicrob Agents Chemother. 48: 3298-3304. doi: 
10.1128/AAC.48.9.3298-3304.2004. 
50. Girard G, Rigali S. 2011. Role of the phenazine-inducing protein Pip in stress 
resistance of Pseudomonas chlororaphis. Microbiology. 157: 398-407. doi: 
0.1099/mic.0.043075-0. 
